Platelet Drug Trial in Coronary Disease Progression

NCT00000496 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia

Interventions

DRUG: aspirin
DRUG: dipyridamole

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)